Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Boehringer Ingelheim
Farmers Insurance
Express Scripts
Moodys
Medtronic
Fish and Richardson
Colorcon
AstraZeneca

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203234

« Back to Dashboard

NDA 203234 describes DESOXIMETASONE, which is a drug marketed by Actavis Mid Atlantic, Akorn, Fougera Pharms, Lupin Atlantis, Perrigo New York, Rising Pharms Inc, Altana, G And W Labs Inc, Glenmark Generics, Novel Labs Inc, Perrigo Israel, Teligent Pharma Inc, and Zydus Pharms Usa Inc, and is included in twenty-four NDAs. It is available from fourteen suppliers. Additional details are available on the DESOXIMETASONE profile page.

The generic ingredient in DESOXIMETASONE is desoximetasone. There are seven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.
Summary for 203234
Tradename:DESOXIMETASONE
Applicant:Akorn
Ingredient:desoximetasone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Pharmacology for NDA: 203234
Medical Subject Heading (MeSH) Categories for 203234
Suppliers and Packaging for NDA: 203234
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESOXIMETASONE desoximetasone CREAM;TOPICAL 203234 ANDA VersaPharm Incorporated 61748-208 61748-208-15 1 TUBE in 1 CARTON (61748-208-15) > 15 g in 1 TUBE
DESOXIMETASONE desoximetasone CREAM;TOPICAL 203234 ANDA VersaPharm Incorporated 61748-208 61748-208-60 1 TUBE in 1 CARTON (61748-208-60) > 60 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.25%
Approval Date:Jun 12, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Julphar
Daiichi Sankyo
Cerilliant
Fuji
Medtronic
AstraZeneca
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot